Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
1. "The Moulouya Fan sand was encountered from 1378 to 1437 metres TVD MD with approximately 50.5 metres of sand versus a pre-drill P50 forecast of 19 metres."
I assume both these measurements are gross intervals, but, the result came out at 2.5 times the P50 forecast? What does that do to @Keith's gas NPVs, which were already off the page relative to PRD's £50mn MC?
2. "A rigless well test over a gross interval of 43 metres within this section between 1379 to 1422 metres TVD MD is planned to be carried out."
So the interval to focus on is this 43m of (gross) gas-prone sands. PRD had previously encountered a low ratio of net to gross pay at MOU-1, which experts here have thought to be highly conservative. What is the baseline net thickness that will move the needle over and above the P50 contingent resource number already disclosed?
Excellent sharing work everyone. Thank you.
...and if there is a 50/50 debt/equity deal being lined up, with, say 250mn shares at 16p making it £40mn+£40mn transaction, will i3e spread the £££ cost of the monthly dividend over that extra share issuance going forward? i.e. cut the per share dividend payment by the amount of the share increase, 17%?
I don't understand why i3e is contemplating raising more equity down at this level, up to 400mn shares, whilst at the same time seeking authority to buy back shares. Which is it?
Must be a heck of a lot of data to process.
Yes sir!
Excuse me. I'm on the wrong exchange, but definitely at the right end of the risk spectrum.
Fred, if you've got a tried and tested exit strategy based on excessive bullish sentiment, then I suggest you stick to it and don't get side railed by the flak on here.
Each to his own, when it comes to successful wealth generation through AIM speculation.
Scoutingforit, maybe you have hit the nail on the head there, with Baker Hughes. I wasn't aware.
Well FWIW, I added again this morning. I'm keeping faith in the management and the assets. The POO will not stay down forever, given the macro supply/demand issues longer term.
KuTo,
Based on AIM exchange experience, can you demonstrate your assertion empirically?
O&W
Hi Pic,
Sorry, I misunderstood your HZM post earlier when you said HZM had a "re-rate of 20 to 1".
This was actually a share consolidation, so no uplift at all in anyone's total invested position.
I still stand by the largest possible % gain from bottom to interim top was 6 times, with perfect hindsight, which no-one ever has!!!
When can we, and the industry professionals, get to see the PK data? Wouldn't that finally put to bed the shorts' last stand against Avct, if confirming that most dox gets through to the TME and does its job?
Ah, but how many of those names sport a 11.5% sustainable dividend yield with upside potential?
Indeed. DTW.
Plus, their word should get around that not only is AV6k with Dox safe but seems to have efficacy beyond their initial expectations.
If only we were on NASDAQ....
Every day, there's a new issue with this pos.
Agreed. A great RNS, advancing the IP value of the preCISION platform, once again, but Mr Market has attributed an incremental £28mn in y. Another slap in the face for one of Britain's best emerging biopharma businesses.
6, actually. Having been here since the 4p+ days, I wouldn't say no that that sort of return.
Strange, but looking at the 5 year graph of HZM, the best gain I can see achievable, with perfect hindsight, is 5 times (30p to 180p).
Wonderful news for end of life cancer patients on the trial.
Can someone please explain, again, why the P1a trial is scheduled to end at C6 cohort, without establishing a MTD?
JV, on the contrary. Both Dice and AVCT have yet to break through their respective 2021 highs. Both have traded broadly sidewways in that time, apart from each dropping off badly at some point.
IBut I would add that the big difference, once again, is AIM vs NASDAQ. No more needs to be said.